PetMed Express (PETS) said late Wednesday its board has approved a one-year extension of its existing shareholder rights plan, pushing expiration to Dec. 2, 2026.
The extension of the shareholder rights plan, commonly known as a poison pill, was adopted to protect shareholders' investment at a time when the pet pharmacy's stock price does not reflect the business's inherent value, the company said.
All the other terms and conditions of the rights plan remain unchanged, it added.
Shares fell over 5% in recent after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments